Cargando…
Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro
Adipose derived mesenchymal stromal/stem cells (ASCs) are a heterogeneous population characterized by (a) their ability to adhere to plastic; (b) immunophenotypic expression of certain cell surface markers, while lacking others; and (c) the capacity to differentiate into lineages of mesodermal origi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023578/ https://www.ncbi.nlm.nih.gov/pubmed/26815002 http://dx.doi.org/10.1007/s10616-016-9945-6 |
_version_ | 1782453660384493568 |
---|---|
author | van Vollenstee, Fiona A. Jackson, Carlo Hoffmann, Danie Potgieter, Marnie Durandt, Chrisna Pepper, Michael S. |
author_facet | van Vollenstee, Fiona A. Jackson, Carlo Hoffmann, Danie Potgieter, Marnie Durandt, Chrisna Pepper, Michael S. |
author_sort | van Vollenstee, Fiona A. |
collection | PubMed |
description | Adipose derived mesenchymal stromal/stem cells (ASCs) are a heterogeneous population characterized by (a) their ability to adhere to plastic; (b) immunophenotypic expression of certain cell surface markers, while lacking others; and (c) the capacity to differentiate into lineages of mesodermal origin including osteocytes, chondrocytes and adipocytes. The long-term goal is to utilize these cells for clinical translation into cell-based therapies. However, preclinical safety and efficacy need to be demonstrated in animal models. ASCs can also be utilized as biological vehicles for vector-based gene delivery systems, since they are believed to home to sites of inflammation and infection in vivo. These factors motivated the development of a labelling system for ASCs using lentiviral vector-based green fluorescent protein (GFP) transduction. Human ASCs were transduced with GFP-expressing lentiviral vectors. A titration study determined the viral titer required to transduce the maximum number of ASCs. The effect of the transduced GFP lentiviral vector on ASC immunophenotypic expression of surface markers as well as their ability to differentiate into osteocytes and adipocytes were assessed in vitro. A transduction efficiency in ASC cultures of approximately 80 % was observed with an MOI of ~118. No significant immunophenotypic differences were observed between transduced and non-transduced cells and both cell types successfully differentiated into adipocytes and osteocytes in vitro. We obtained >80 % transduction of ASCs using GFP lentiviral vectors. Transduced ASCs maintained plastic adherence, demonstrated ASC immunophenotype and the ability to differentiate into cells of the mesodermal lineage. This GFP-ASC transduction technique offers a potential tracking system for future pre-clinical studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10616-016-9945-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5023578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-50235782016-09-27 Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro van Vollenstee, Fiona A. Jackson, Carlo Hoffmann, Danie Potgieter, Marnie Durandt, Chrisna Pepper, Michael S. Cytotechnology Original Article Adipose derived mesenchymal stromal/stem cells (ASCs) are a heterogeneous population characterized by (a) their ability to adhere to plastic; (b) immunophenotypic expression of certain cell surface markers, while lacking others; and (c) the capacity to differentiate into lineages of mesodermal origin including osteocytes, chondrocytes and adipocytes. The long-term goal is to utilize these cells for clinical translation into cell-based therapies. However, preclinical safety and efficacy need to be demonstrated in animal models. ASCs can also be utilized as biological vehicles for vector-based gene delivery systems, since they are believed to home to sites of inflammation and infection in vivo. These factors motivated the development of a labelling system for ASCs using lentiviral vector-based green fluorescent protein (GFP) transduction. Human ASCs were transduced with GFP-expressing lentiviral vectors. A titration study determined the viral titer required to transduce the maximum number of ASCs. The effect of the transduced GFP lentiviral vector on ASC immunophenotypic expression of surface markers as well as their ability to differentiate into osteocytes and adipocytes were assessed in vitro. A transduction efficiency in ASC cultures of approximately 80 % was observed with an MOI of ~118. No significant immunophenotypic differences were observed between transduced and non-transduced cells and both cell types successfully differentiated into adipocytes and osteocytes in vitro. We obtained >80 % transduction of ASCs using GFP lentiviral vectors. Transduced ASCs maintained plastic adherence, demonstrated ASC immunophenotype and the ability to differentiate into cells of the mesodermal lineage. This GFP-ASC transduction technique offers a potential tracking system for future pre-clinical studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10616-016-9945-6) contains supplementary material, which is available to authorized users. Springer Netherlands 2016-01-27 2016-10 /pmc/articles/PMC5023578/ /pubmed/26815002 http://dx.doi.org/10.1007/s10616-016-9945-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article van Vollenstee, Fiona A. Jackson, Carlo Hoffmann, Danie Potgieter, Marnie Durandt, Chrisna Pepper, Michael S. Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
title | Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
title_full | Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
title_fullStr | Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
title_full_unstemmed | Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
title_short | Human adipose derived mesenchymal stromal cells transduced with GFP lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
title_sort | human adipose derived mesenchymal stromal cells transduced with gfp lentiviral vectors: assessment of immunophenotype and differentiation capacity in vitro |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023578/ https://www.ncbi.nlm.nih.gov/pubmed/26815002 http://dx.doi.org/10.1007/s10616-016-9945-6 |
work_keys_str_mv | AT vanvollensteefionaa humanadiposederivedmesenchymalstromalcellstransducedwithgfplentiviralvectorsassessmentofimmunophenotypeanddifferentiationcapacityinvitro AT jacksoncarlo humanadiposederivedmesenchymalstromalcellstransducedwithgfplentiviralvectorsassessmentofimmunophenotypeanddifferentiationcapacityinvitro AT hoffmanndanie humanadiposederivedmesenchymalstromalcellstransducedwithgfplentiviralvectorsassessmentofimmunophenotypeanddifferentiationcapacityinvitro AT potgietermarnie humanadiposederivedmesenchymalstromalcellstransducedwithgfplentiviralvectorsassessmentofimmunophenotypeanddifferentiationcapacityinvitro AT durandtchrisna humanadiposederivedmesenchymalstromalcellstransducedwithgfplentiviralvectorsassessmentofimmunophenotypeanddifferentiationcapacityinvitro AT peppermichaels humanadiposederivedmesenchymalstromalcellstransducedwithgfplentiviralvectorsassessmentofimmunophenotypeanddifferentiationcapacityinvitro |